SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001415889-14-001174
Filing Date
2014-04-15
Accepted
2014-04-15 16:54:02
Documents
6
Period of Report
2014-04-11
Effectiveness Date
2014-04-15

Document Format Files

Seq Description Document Type Size
1 ectedef14a_apr2014.htm DEF 14A 462287
2 proxy1.jpg GRAPHIC 199414
3 proxy2.jpg GRAPHIC 161033
4 ectedef14a_apr20140.jpg GRAPHIC 3989
5 sig1.jpg GRAPHIC 4402
6 sig2.jpg GRAPHIC 7553
  Complete submission text file 0001415889-14-001174.txt   982860
Mailing Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103
Business Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103 215-717-4100
Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)

IRS No.: 411649949 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35218 | Film No.: 14765546
SIC: 3845 Electromedical & Electrotherapeutic Apparatus